ABSTRACT
Diabetes mellitus (DM) is a chronic metabolic disorder which requires continuous medical care. Today all the world is facing a kind of type 2 DM pandemic. [1, 2] According to the results of Turkey Diabetes Epidemiology Survey II (TURDEP), the prevalence of diabetes among Turkish adults has reached 13.7%. [3, 4] Type 2 DM is leading cause of mortality and morbidity due to both prevalence and acute and chronic complications. [5] The most significant causes of mortality and morbidity are cardiovascular diseases (CVD). The vascular complications can be in forms of micro-or macroangiopathy. Retinopathy, nephropathy and neuropathy are the most crucial microvascular complications. Together with hyperglycemia, hypertension (HT), smoking, dyslipidemia and obesity may also lead to microangiopathy. [6, 7] Especially in western countries, nephropathy is the main reason for end stage renal failure. It follows a path which starts with microalbuminuria and goes with constant proteinuria and deteriorating azotemia. [8] Diabetic retinopathy is divided into two groups as nonproliferative and proliferative diabetic retinopathy. Diabetic retinopathy is the most significant cause of blindness in the world. [9] Diagnosing the arterial stiffness parameters are one of the most effective methods in determining the elastic features of arteries. Pulse wave velocity (PWV) and augmentation index (Alx) are indexes of arterial stiffness. [10, 11] Diabetic patients stand for the independent risk group for CVD. In diabetic patients, thickening occurs in intima and media layers and atherosclerotic process speeds up owing to vascular stress and endothelial damage. Our aim is to define the relationship between obesity and microvascular complications with PWV and Alx, and to evaluate the usefulness of this test in predicting prognosis of the patients. Patients were divided into groups in respect to HT, HL and DM treatment. The ones who are treated for hypertension and hyperlipidemia are marked as "positive" and the ones who aren't treated for these disease are marked as "negative". Four categorizations were used for type 2 DM treatment. These are: arterial stiffness measurement A single cuffed arteriograph device (I.E.M. GmbH brand Mobil-O-Graph PWA, a model pulse wave analysis device) was used for the arterial stiffness measurements, which is using a validated oscillometric technique. [12, 13] The participants included in the study were made to rest for 10 min before measurement, and were required not to smoke or drink any caffeinated beverages in the 30 min leading up to measurement. Prior to measurement, the date of birth, height, weight, and smoking status of each patient were entered into the software program of the device, and the cuff was attached to side of the upper arm on the brachial artery trace. The cuff was held in line with the heart, and the device took two measurements automatically at 30-s intervals. [14] [15] [16] PWV, Alx, systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), heart rate of patients were recorded by this machine. 
Patients anD MetHODs

ResULts
Since 12 of these patients' estimated glomerular filtration rate (eGFR) were found to be less than 30 mL/min/1.73 m 2 ; two of the patients didn't apply to us after blood examination, four patients were diagnosed to have coronary artery disease backgrounds after the detailed examination of the anamnesis, these patients weren't taken into study. (Figure 1 ). There was a statistical positive relation between Alx and BMI, SBP and heart rate (HR) values; and a statistical negative relation with hemoglobin (Hb) value (in order p=0.025, p=0.019, p<0.001, p=0.024) ( Table 2) .
Fifty-seven patients (51.8%) were diagnosed with HT, 51 patients (46.4%) were diagnosed (Figure 2, 3) . Some parameters which are likely to effect the reason for low Alx in smoking patients were taken into consideration. The relation between smoking and WC, CI, BMI was examined. Despite not being statically illogical, non-smokers were defined to have higher BMI, CI and WC (Table 3) .
Twenty-nine patients (26.4%) were diagnosed with diabetic retinopathy; 81 patients (73.6%) weren't diagnosed diabetic retinopathy. Ten patients (9.1%) with diabetic retinopathy were diagnosed with PDR, 19 (17.3%) of them were diagnosed with NPDR. Thirty (27.3%) of the patients were diagnosed with nephropathy while 80 (72.7%) of them weren't. Twentyone (19.1%) of the patients with nephropathy were in microalbuminuric phase, nine (8.2%) of them were in macroalbuminuric phase. No statistical distinction of diabetes complications (nephropathy and retinopathy) was seen with PWV and AI (Table 4) .
Fifty-five (50%) of the patients were using an antihypertensive medication, 32 (29.1%) of them were using an antihyperlipidemic medication; while 55 (50%) of them were not using any antihypertensive medication and 78 (70.9%) of them weren't using any antihyperlipidemic medication. The patients being treated for type 2 DM were defined as: 2 (18%) Dieting, 
DisCUssiOn
Arterial stiffness leads to prediction of CVD in general population, hypertensive patients and diabetics. The golden standard in measurement of arterial stiffness is aortic PWV measurement. PWV measurement in office conditions contributes to prediction of cardiovascular complications beyond other risk factors. Each one standard deviation rise in PWV value leads to 16-20% rise in the risk of CVD. [17] In this study a statistically positive relation was diagnosed between PWV and type 2 DM duration, HDL, SBP, MAP values. In a study by Theilade et al. [18] in type 1 DM patients, a positive correlation (r=0.54) between PWV and diabetes duration was seen. In a study by Cruickshank et al. [19] it was seen that as glucose tolerance fell, PWV values rose.
Conicity index and BMI, which are antropometric measurements and used for obesity, were also looked in this study. A statistically meaningful correlation was seen between PWV and CI. The patients who have renal failure criteria were examined in the study of Evans et al. [20] and it was seen that there was a statistically negative association between BMI and PWV. In the same study it was found that as the CI value of the patients increased their PWV value increased (p<0.001).
There was no statistically significant correlation between PWV and albuminuria level which shows nephropathy stage. In the study of Theilade et al. [18] a positive correlation between PWV and excretion ratio was found. Also it was seen in the same study that in normoalbuminuric type 1 DM patients, PWV was relatively high in comparison to control group. This finding supports the idea of the relation between of DM existence and arterial stiffness in early stages. In our study a statistically meaningful negative relation was seen between PWV and eGFR. Same findings were seen in the study of Theilade et al. [18] and Smith et al. [21] It was also shown that as a falling occurs in creatinine clearance in the patients who don't have DM and end stages renal disease, PWV rose. [22, 23] It can be thought that early modifications in renal functions not only trigger stiffness in small arteries but also in big arteries. With the studies conducted, the essential factors that determine PWV values are: age, gender, PWV, albumin/creatinine proportion, diabetes duration, the number of antihypertensive medicine, ACEI/ARB usage, creatinine clearance, fasting plasma glucose. [21, 22] In our study the ones with HT story were found to have statistically higher PWV values than the ones who don't have a HT story. In the study of Cruickshank et al. [19] the findings are similar to ours. After the long-term follow-up of this study, in died patients PWV was about 2.6 m/sec higher and SBP was 10 mmHg higher in comparison to living patients. In terms of mortality PWV was diagnosed to be relatively predictive.
In different studies, some pharmacologic agents were studied in terms of arterial stiffness. In the ones who use more antihypertensive, ACE/ ARB and take antihypertensive treatment like in our study, PWV was seen to be higher. [18, 21] These findings points to vascular disease which has been going on longer. CAFE study showed that the effect of antihypertensive treatment on central blood pressure, in comparison with effect on lowering the blood pressure, is a better indicator in reflecting the cardiovascular conditions. [24] There are contradictory information between diabetes treatment and PWV. In our study, a statistically meaningful distinction wasn't seen in terms of PWV and Alx values between, the patient groups who were divided into groups according to their diet, exercise, oral antidiabetic and insulin treatments. In a study by Kim et al. [25] it was shown that rosiglitazone decreases PWV by increasing the insulin sensitivity. In another study it was shown that insulin treatment increases PWV [26] possibly due to increased anabolic effects of insulin. This subject hasn't been fully clarified yet and so bigger studies are needed.
In our study, a reverse relation between smoking and Alx was seen. So, when the other parameters that may effect arterial stiffness were examined it was seen that BMI and CI in nonsmokers were higher. It can be thought that BMI and CI may be as effective as cigarette in effecting arterial stiffness.
In comparison with other studies [18, 27] no relation between retinopathy and arterial stiffness was seen. This may be due to the small number of our patient group. Some studies have been carried out to evaluate the relation between PWV and inflammation paremeters. The inflammation parameters which show subclinic organ damage (C reactive protein, interleukin-6, tumor necrosis factor alpha) are connected with PWV. [28] [29] [30] [31] In our study uric acid values were examined as the indirect parameter of inflammation. No statistically meaningful relation between PWV values and uric acid level was seen.
Conclusion
The CI, eGFR hemoglobin, diabetes duration and arterial blood pressure of patients with DM were found to be related with arterial stiffness. No relation between nephropathy and retinopathy with arterial stiffness were seen. Diabetes mellitus is equal to coronary artery disease. Arterial stiffness is used as a predicting parameter for coronary artery disease. We are of the opinion that arterial stiffness is a novel risk factor of CVD for obesity, anemia, essential hypertension and in type 2 DM patient group.
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